DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer ; volume:4 ; number:1 ; day:13 ; month:7 ; year:2012 ; pages:1-11 ; date:12.2012
Clinical epigenetics ; 4, Heft 1 (13.7.2012), 1-11, 12.2012
- Creator
-
Letelier, Pablo
- Contributor
-
Brebi, Priscilla
Tapia, Oscar
Roa, Juan Carlos
SpringerLink (Online service)
- DOI
-
10.1186/1868-7083-4-11
- URN
-
urn:nbn:de:1111-2016072634044
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Letelier, Pablo
- Brebi, Priscilla
- Tapia, Oscar
- Roa, Juan Carlos
- SpringerLink (Online service)
Other Objects (12)
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation
Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis
Gene Promoter Methylation in Endometrial Carcinogenesis
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer
Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
Methylation of the OPRM1 promoter during alcohol withdrawal
AQP5-1364A/C polymorphism affects AQP5 promoter methylation
Promoter methylation regulates cyclooxygenase expression in breast cancer
SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy
C-reactive protein in gallbladder diseases: diagnostic and therapeutic insights
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation
Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis
Gene Promoter Methylation in Endometrial Carcinogenesis
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer
Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
Methylation of the OPRM1 promoter during alcohol withdrawal
AQP5-1364A/C polymorphism affects AQP5 promoter methylation
Promoter methylation regulates cyclooxygenase expression in breast cancer
SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy
C-reactive protein in gallbladder diseases: diagnostic and therapeutic insights
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation
Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis
Gene Promoter Methylation in Endometrial Carcinogenesis
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer
Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
Methylation of the OPRM1 promoter during alcohol withdrawal
AQP5-1364A/C polymorphism affects AQP5 promoter methylation
Promoter methylation regulates cyclooxygenase expression in breast cancer
SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy